Galena Biopharma (GALE) Issues Update to FBP-E39 Phase 1/2 at ASCO

June 3, 2013 7:07 AM EDT Send to a Friend
Galena Biopharma (Nasdaq: GALE) announced two publications at the American Society of Clinical Oncologists (ASCO) 2013 Annual Meeting taking place ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login